| Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co.'s products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Co.'s portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis.Co.'s portfolio of sequencing platforms represents a family of systems that are used by customers to perform whole-genome, de novo, exome and ribonucleic acid sequencing, and targeted resequencing of specific gene regions and genes. We show 40 historical shares outstanding datapoints in our coverage of ILMN's shares outstanding history.|
Understanding the changing numbers of ILMN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ILMN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ILMN by allowing them to research ILMN shares outstanding history
as well as any other stock in our coverage universe.